Cita APA (7a ed.)

T, W., T, W., H, L., B, H., S, H., C, W., . . . H, X. (2019). Arsenic sulfide nanoformulation induces erythroid differentiation in chronic myeloid leukemia cells through degradation of BCR-ABL. Dove Medical Press.

Cita Chicago Style (17a ed.)

T, Wang, et al. Arsenic Sulfide Nanoformulation Induces Erythroid Differentiation in Chronic Myeloid Leukemia Cells Through Degradation of BCR-ABL. Dove Medical Press, 2019.

Cita MLA (8a ed.)

T, Wang, et al. Arsenic Sulfide Nanoformulation Induces Erythroid Differentiation in Chronic Myeloid Leukemia Cells Through Degradation of BCR-ABL. Dove Medical Press, 2019.